A Phase 2, Randomized Withdrawal Study of the Analgesic Efficacy and Safety of ABT-652 as an Add On Therapy in Subjects With Osteoarthritis of the Knee Experiencing Partial Benefit of a Nonsteroidal Anti-Inflammatory Drug.
Phase of Trial: Phase II
Latest Information Update: 14 May 2013
At a glance
- Drugs ABT 652 (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- 27 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Apr 2012 Actual patients number is 202 as reported by ClinicalTrials.gov.
- 24 Feb 2012 Planned End Date changed from 1 Mar 2012 to 1 Apr 2012 as reported by ClinicalTrials.gov.